Dr André Tchouatieu has more than 20 years of experience in delivery and access to health care in Africa. Currently, he is the Director of Access and Product Management at Medicines for Malaria Venture(MMV), a Geneva-based product development partnership where he leads the chemoprevention strategy looking at how best antimalarial medicines can be used preventatively to protect people in endemic countries. Before MMV, he spent 12years with Sanofi as country manager in Burundi, Medical Advisor for Eastern Africabased in Nairobi, and Global Malaria Senior Medical Manager in Paris. Before Sanofi, André had served as a field physician with Médecins Sans Frontières in East Africa. His interests are in access and quality of care in Africa and, particularly access to good quality medicines, focusing on malaria as one of the major public health issues in Africa. He holds a medical doctorate from the University of Burundi, with specialist training in health economy and health system strengthening from the University of Basle. Alumni of The Science for Malaria Eradication course from Swiss TPH, ISGlobal and Havard University.